News Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages GAITHERSBURG, Md., Sept. 26, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its…Super UserSeptember 29, 2022
News President Biden Announces Intent to Appoint Dr. Renee Wegrzyn as Inaugural Director of Advanced Research Projects Agency for Health (ARPA-H) – The White House Today, President Joe Biden announced his intent to appoint Dr. Renee Wegrzyn as the first director of the Advanced Research…Super UserSeptember 29, 2022
News Neuroene Therapeutics Wins 7th Annual BioHealth Capital Region Crab Trap Competition ROCKVILLE, MARYLAND, September 26, 2022 – When it was announced that the winner of the 7th Annual BioHealth Capital Region Crab Trap…Super UserSeptember 26, 2022
News BioBuzz: Neuroene Therapeutics Wins 7th Annual Crab Trap Competition Gaithersburg-based Neuroene Therapeutics and its approach to treating a rare form of epilepsy were crowned the winner of the seventh annual…Super UserSeptember 26, 2022
News Sarah Miller with BHI – Excited to be a panelist for this timely discussion. BaneBio is proud to be a sponsor of this invite-only VIP panel event I-270 Innovation Labs. (more…)Super UserSeptember 26, 2022
News Game changers: Regional effort links academics and entrepreneurs with economic development Startups. Capital. Entrepreneurship. These weren’t always terms in Amy White’s daily lexicon. A trained scientist, White dedicated 15 years to…Super UserSeptember 26, 2022
News Emergent BioSolutions inks deal for smallpox newcomer Tembexa Emergent BioSolutions, already flush with products against public health threats like anthrax attacks and opioid overdoses, is expanding its arsenal…Super UserSeptember 26, 2022
News Senate pulls SBIR back from brink of sunsetting | Federal News Network The Small Business Innovation Research program is a big step further away from ending. The Senate passed a three-year authorization…Super UserSeptember 26, 2022
News HemoShear Therapeutics Advancing Novel Modulators Against Second Target for Horizon Therapeutics’ Gout Discovery Pipeline Fifth Milestone Achieved by HemoShear with Novel Compounds for Second Target CHARLOTTESVILLE, Va., Sept. 21, 2022 /PRNewswire/ -- HemoShear Therapeutics, Inc., a…Super UserSeptember 26, 2022
News University of Maryland, Baltimore and Wexford Meeting Critical Demand for Wet Lab Space in Baltimore Region | UM BioPark Doubling the University of Maryland BioPark's lab space, the two-phase 4MLK development project will represent more than $320 million in…Super UserSeptember 26, 2022